Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with 99mTc-MIBI and 18F-FDG

NuklearMedizin

Volumn 44, Issue 3, 2005, Pages

  Meller, B ^a   Sahlmann, C ^b   Horstmann, O ^b   Gerl, J ^c   Baehre, M ^a   Meiler, J ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c GSI HELMHOLTZZENTRUM FÜR SCHWERIONENFORSCHUNG GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOACTIVE IODINE; THYROGLOBULIN;

ADULT; ARTICLE; CASE REPORT; DRUG UPTAKE; HUMAN; LASER SURGERY; LUNG METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; RECURRENT CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID CARCINOMA;

FLUORODEOXYGLUCOSE F18; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOPHARMACEUTICALS; RADIOSURGERY; TECHNETIUM TC 99M SESTAMIBI; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 20444442025     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Dietlein M, Scheidhauer K, Voth E et al. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm? Nuklearmedizin 1998; 37: 12-7.
2. Dietlein, M, Dressier J, Eschner W et al. Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 2) Nuklearmedizin 2003; 42: 123-5.
3. 18F-fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res 2001; 96: 120-6.
4. 131I. Nuklearmedizin 1995; 34: 127-34.
5. Grünwald F, Kalicke T, Feine U et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study, Eur J Nucl Med 1999; 26: 1547-52.
6. Hyde NC, Prvulovich E, Newman L et al. A new approach to pretreatment assessment of the NO neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 2003; 39: 350-60.
7. Moog F, Linke R, Manthey N et al. Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma. J Nucl Med 2000; 41: 1989-95.
8. 99mTc-MIBI radio-guided surgery for recurrent thyroid carcinoma: technical feasibility and procedure, and preliminary clinical results. Eur J Nucl Med Mol Imaging 2002; 9: 1201-5.
9. Salvatori M, Rufini V, Reale F et al. Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg 2003; 27: 770-5.
10. Shoaib T, Soutar DS, MacDonald DG et al. The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically NO neck. Cancer 2001; 91: 2077-83.
11. Sophocleous S, Ehrenheim C, Fischer J et al. Low-risk- Schilddrüsenkarzinom-Therapie, Nachsorge und Prognose. Nuklearmedizin 1997; 36: 93-102.
12. 131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 1998; 83: 2675-80.
13. 18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study. J Surg Res 2001; 97: 9-13.